This topic contains a solution. Click here to go to the answer

Author Question: A client has been selected as a participant in the approval process of a particular drug. The ... (Read 37 times)

Yolanda

  • Hero Member
  • *****
  • Posts: 757
A client has been selected as a participant in the approval process of a particular drug. The client's dose and any effects from the medication are being monitored. Which phase of drug approval is this client participating in?
 
  1. Post-marketing study
  2. Clinical phase trial
  3. Postclinical investigation
  4. Preclinical investigation

Question 2

Which phase of clinical research involves basic science research?
 
  1. Submission of NDA
  2. Clinical phase trials
  3. Post-marketing study
  4. Preclinical investigation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

owenfalvey

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

Correct Answer: 4

Rationale 1: Post-marketing studies take place after clinical trials to check for any new harmful effects in a larger and more diverse population.
Rationale 2: Clinical investigation is the second and longest part of the drug approval process, and takes place in three different phases, termed clinical phase trials. During this phase, clinical investigators address concerns such as whether the drug worsens other medical conditions; establish drug doses; and try to identify adverse effects.
Rationale 3: Postclinical investigation is not a phase of the approval process.
Rationale 4: Preclinical investigation involves basic science research.

Global Rationale: Preclinical investigation involves basic science research. Post-marketing studies take place after clinical trials to check for any new harmful effects in a larger and more diverse population. Clinical investigation is the second and longest part of the drug approval process, and takes place in three different phases, termed clinical phase trials. During this phase, clinical investigators address concerns such as whether the drug worsens other medical conditions; establish drug doses; and try to identify adverse effects. Postclinical investigation is not a phase of the approval process.

Answer to Question 2

Correct Answer: 4

Rationale 1: A review of the NDA is the third stage of drug approval. During this stage, clinical phase III trials and animal testing may continue, depending on the results obtained from preclinical testing. If the NDA is approved, the process continues to the final stage. If the NDA is rejected, the process stops until concerns are addressed.
Rationale 2: During these phases, clinical pharmacologists, researchers, and health care providers examine data from volunteers and large groups of selected patients with certain diseases.
Rationale 3: Post-marketing surveillance is the fourth stage of the drug approval process. It takes place after clinical trials and the NDA review process have been completed. Testing in humans is continued to check for any new harmful effects in larger and more diverse populations.
Rationale 4: Preclinical investigation involves basic science research.

Global Rationale: Preclinical investigation involves basic science research. A review of the NDA is the third stage of drug approval. During this stage, clinical phase III trials and animal testing may continue, depending on the results obtained from preclinical testing. If the NDA is approved, the process continues to the final stage. If the NDA is rejected, the process stops until concerns are addressed. During these phases, clinical pharmacologists, researchers, and health care providers examine data from volunteers and large groups of selected patients with certain diseases.




Yolanda

  • Member
  • Posts: 757
Reply 2 on: Jul 24, 2018
:D TYSM


diana chang

  • Member
  • Posts: 288
Reply 3 on: Yesterday
Excellent

 

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

For a complete list of videos, visit our video library